References
- Pharmacological basis of therapeutics, L. S. Goodman, A. Gilman. Macmillian Publishing Company, New York 1980
- Grabowska M., Antkiewicz L., Michaluk J. A possible interaction of quipazine with central dopamine structures. Journal of Pharmacy and Pharmacology 1974; 26: 74–76
- Green A., Youdin M., Grahame-Smith D. H. Quipazine: Its effects on rat brain 5-hydroxytryptamine metabolism, monoamine oxidase activity, and behavior. Neuropharmacology 1976; 15: 173–179
- Hollister A., Breese G., Kuhn C., Cooper B., Schanberg S. An inhibitory role for brain serotonin-containing systems in the locomotor activity effects of d-amphetamine. Journal of Pharmacology and Experimental Therapeutics 1976; 198: 12–23
- Mabry P., Campbell B. Serotonergic inhibition of catecholamine induced behavioral arousal. Brain Research 1973; 49: 381–391
- Malik J., Doren E., Barnett A. Quipazine induced head twitch in mice. Pharmacology, Biochemistry and Behavior 1977; 6: 325–329
- Medon P., Leeling J., Phillips B. Influence of quipazine, a potent anti-Parkinson agent on the uptake of 3H-dopamine and 3H-serotonin in rat striatal tissue in vitro. Life Sciences 1973; 13: 685–691
- Meites J. Catecholamines and prolactin secretion. Advances in Biochemical Pharmacology 1977; 16: 139–146
- Meltzer H., Fessler M., Simonovic Doherty J.J, Fang V. Lysergic acid diethylamide: Evidence for stimulation of pituitary dopamine receptors. Psychopharmacology 1977; 54: 39–44
- Meltzer H., Fang V., Pual S., Kalusar R. Effect of quipazine on rat plasma prolactin levels. Life Sciences 1976; 19: 1073–1078
- Rodriquez R. Antagonism of tremorine induced tremor by serotonergic agents in mice. Life Sciences 1972; 11: 535–544
- Rodriguez R., Pardo E. Quipazine: A new type of antidepressant agent. Psychopharmacology 1971; 21: 89–100
- Weiner W., Goetz C., Klawans H. L. Serotonergic and antiserotonergic influences on apomorphine induced stereotypy. Acta Pharmacologia et Toxicologia 1975; 36: 155–160